A carregar...
Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
Rituximab is an anti-CD20 monoclonal antibody frequently used for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and anti-neutrophilic cytoplasmic antibody (ANCA)-associated vasculitis. In addition, rituximab has recently been increasingly use...
Na minha lista:
| Publicado no: | J Renal Inj Prev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nickan Research Institute
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414514/ https://ncbi.nlm.nih.gov/pubmed/28487867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/jrip.2017.04 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|